Skip to main content
PFE
NYSE Life Sciences

FDA Approves Pfizer's Palbociclib Combo for Metastatic Breast Cancer Maintenance

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$24.245
Mkt Cap
$138.183B
52W Low
$23.11
52W High
$28.745
52W Position info
4.9% above low
Off High info
16% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PFE is trading near its 52-week low of $23.11 (4.9% above the low).

Summary

The FDA has approved Pfizer's Palbociclib combination therapy for the maintenance treatment of HR-positive, HER2-positive metastatic breast cancer. This expands the label for Palbociclib, an existing key oncology drug, into a new patient population. The approval strengthens Pfizer's oncology portfolio and offers new revenue potential from an established product.

At the time of this announcement, PFE was trading at $24.25 on NYSE in the Life Sciences sector, with a market capitalization of approximately $138.2B. The 52-week trading range was $23.11 to $28.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 18, 2026, 7:20 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.28
Real-time Price: $28.30 info
Change: +$0.015 (+0.05%) info
Market Cap: $161.391B info
PFE
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.12
Real-time Price: $28.30 info
Change: -$0.825 (-3%) info
Market Cap: $161.391B info
PFE
Nov 13, 2026, 3:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.85
Real-time Price: $28.30 info
Change: -$0.5575 (-2%) info
Market Cap: $161.391B info
PFE
Nov 11, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $28.30 info
Change: -$1.15 (-4%) info
Market Cap: $161.391B info
PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $28.30 info
Change: -$2.36 (-8%) info
Market Cap: $161.391B info